SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001664710-21-000026
Filing Date
2021-05-06
Accepted
2021-05-06 16:20:50
Documents
29
Period of Report
2021-05-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K keros-form8xkcorporatedeck.htm 8-K 31566
2 EX-99.1 kerostherapeutics-corpor.htm EX-99.1 29046
3 GRAPHIC kerostherapeutics-corpor001.jpg GRAPHIC 104936
4 GRAPHIC kerostherapeutics-corpor002.jpg GRAPHIC 248069
5 GRAPHIC kerostherapeutics-corpor003.jpg GRAPHIC 189968
6 GRAPHIC kerostherapeutics-corpor004.jpg GRAPHIC 115210
7 GRAPHIC kerostherapeutics-corpor005.jpg GRAPHIC 101731
8 GRAPHIC kerostherapeutics-corpor006.jpg GRAPHIC 144483
9 GRAPHIC kerostherapeutics-corpor007.jpg GRAPHIC 143369
10 GRAPHIC kerostherapeutics-corpor008.jpg GRAPHIC 133356
11 GRAPHIC kerostherapeutics-corpor009.jpg GRAPHIC 138091
12 GRAPHIC kerostherapeutics-corpor010.jpg GRAPHIC 145049
13 GRAPHIC kerostherapeutics-corpor011.jpg GRAPHIC 105534
14 GRAPHIC kerostherapeutics-corpor012.jpg GRAPHIC 118133
15 GRAPHIC kerostherapeutics-corpor013.jpg GRAPHIC 103047
16 GRAPHIC kerostherapeutics-corpor014.jpg GRAPHIC 143369
17 GRAPHIC kerostherapeutics-corpor015.jpg GRAPHIC 99820
18 GRAPHIC kerostherapeutics-corpor016.jpg GRAPHIC 117471
19 GRAPHIC kerostherapeutics-corpor017.jpg GRAPHIC 140025
20 GRAPHIC kerostherapeutics-corpor018.jpg GRAPHIC 135607
21 GRAPHIC kerostherapeutics-corpor019.jpg GRAPHIC 215412
22 GRAPHIC kerostherapeutics-corpor020.jpg GRAPHIC 110660
23 GRAPHIC kerostherapeutics-corpor021.jpg GRAPHIC 145517
24 GRAPHIC kerostherapeutics-corpor022.jpg GRAPHIC 104776
25 GRAPHIC kerostherapeutics-corpor023.jpg GRAPHIC 151866
26 GRAPHIC kerostherapeutics-corpor024.jpg GRAPHIC 86435
27 GRAPHIC kerostherapeutics-corpor025.jpg GRAPHIC 163986
28 GRAPHIC kerostherapeutics-corpor026.jpg GRAPHIC 95559
29 GRAPHIC kerostherapeutics-corpor027.jpg GRAPHIC 83599
  Complete submission text file 0001664710-21-000026.txt   5002982
Mailing Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421 617-513-8774
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39264 | Film No.: 21898125
SIC: 2834 Pharmaceutical Preparations